Clinical Edge Journal Scan

Clinical Edge Journal Scan

Beta-defensin-2 may serve as a predictive biomarker for clinical response to secukinumab in PsA

• Read More

Clinical Edge Journal Scan

Commentary: Evaluating new and established treatments for PsA, July 2023

Author:

Vinod Chandran, MBBS, MD, DM, PhD

• Read More

Clinical Edge Journal Scan

High physical activity reduces visceral fat mass and percentage body fat in PsA

• Read More

Clinical Edge Journal Scan

Higher disease burden among women with PsA vs RA

• Read More

Clinical Edge Journal Scan

Patients with PsA, especially women, likely to have abnormal sleep behavior

• Read More

Clinical Edge Journal Scan

Serum interleukin-36 alpha: A potential biomarker to differentiate PsA from Behçet’s syndrome

• Read More

Clinical Edge Journal Scan

No clinically meaningful difference in response to ustekinumab in younger vs older patients with PsA

• Read More

Clinical Edge Journal Scan

Apremilast significantly improves dactylitis and enthesitis in PsA

• Read More

Clinical Edge Journal Scan

Axial spondyloarthritis and PsA with axial involvement are distinct entities

• Read More

Clinical Edge Journal Scan

Etanercept safe and effective in juvenile psoriatic arthritis

• Read More